White Papers
Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM)
White Paper Risk-Based Quality Management Technology-Driven CRO: Optimizing Oncology Clinical Development Programs Via Risk-Based Quality Management (RBQM) There are currently […]
March 31, 2023
Optimizing Oncology Trials via Remote Monitoring
White Paper OPTIMIZING ONCOLOGY TRIALS via Remote Monitoring Within the oncology drug development pipeline, which has increased by over 60% […]
March 31, 2023
Critical Considerations for Rare & Orphan Disease Trial Planning
Critical Characteristics in Identifying a Rare Disease CRO Partner A Question-First Approach to Operationalizing Rare Disease Studies This Atlantic Research […]
March 31, 2021
Rare Perspectives: Factor X Deficiency
Factor X Deficiency Keys To Clinical Trial Success In Rare Disease Indications This Atlantic Research Group rare disease case study […]
March 31, 2020
Patient Centricity in a Consumer Model
White Paper: Patient Centricity in a Consumer Model This Atlantic Research Group rare disease white paper is available for download […]
March 31, 2019